301089.SZ
Tuoxin Pharmaceutical Group Co., Ltd.
SZSE · C 制造业 · CN
CNY 23.14
−4.38%Year over year
Reported trailing growth
- Revenue
- -8.9%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- +28.9%
- Operating cash flow
- -98.2%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -21.6%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026